Status:
COMPLETED
Effect of Erythropoietin (EPO) in Kidney After Cardiac Surgery
Lead Sponsor:
Seoul National University Bundang Hospital
Conditions:
Kidney Failure, Acute
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to determine whether erythropoietin is effective in preventing acute kidney dysfunction after coronary artery bypass grafting surgery.
Detailed Description
Acute kidney injury (AKI) occurs in 7% to 40% of patients undergoing cardiac surgery, depending on the definition of AKI used. Even small increments in serum creatinine have been shown to be associate...
Eligibility Criteria
Inclusion
- Patients scheduled for elective CABG over age 18
Exclusion
- Under age 18
- Emergent CABG
- Prior exposure to nephrotoxic drug
- Dialysis patients
- Uncontrolled hypertension
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT00654992
Start Date
September 1 2006
End Date
February 1 2009
Last Update
June 16 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea, 463-707